PCI Announces Expansion of Packaging Capacity
News Mar 14, 2014
Packaging Coordinators, Inc. (PCI) has announced the completion of the planned expansion of its packaging facilities in Rockford, IL.
The Rockford site is one of three locations in the United States, and the facilities expansion in Rockford was designed to accommodate continued business development in its contract packaging services.
PCI converted underutilized space to further support its expanding packaging operations, adding 20,000 square feet for secondary and tertiary packaging. The additional production capacity will enable continued growth in operations such as cartoning, overwrapping, heat seal carding and compliance prompting packaging, as well as supporting packaging for biotech delivery forms such as secondary packaging for injectable vials, syringes, devices, and transdermal products. The packaging operations support both commercial operations as well as large-scale clinical studies.
In addition to packaging of commercial medicines, PCI provides clinical packaging services for investigational medicines at the Rockford location supported by on-site Storage and Distribution Services, facilitating global logistics for clinical studies.
In December 2013 PCI has announced the groundbreaking of a new 93,000 square foot Storage and Distribution site for investigational medicines, currently slated to be in operation in August of this year.
The clinical services expansion complements investments in PCI’s UK operations, most recently construction of a Storage and Distribution facility near Cardiff, Wales.
“The facilities expansion we have undertaken in Rockford is the latest in a series of investments we have made to enable continued growth and at the same time continue to provide our customers the extraordinary service they have come to expect from PCI,” states Bill Mitchell, President and Chief Executive Officer at PCI. “We are committed to providing an unparalleled customer experience with our clinical and commercial services, and those services require world class facilities. We are very excited about what these investments bring to our expanding business and our ability to support our clients.”
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018